Genentech Caps Cost of Cancer Drug for Some Patients
<p class="source">The New York Times</p>
<p>It is not clear whether Genentech's move will mollify critics. Jerry Flanagan, health care policy director at the Foundation for Taxpayer and Consumer Rights, a consumer group in Santa Monica, Calif., said that Genentech ''cannot expect that this will appease patients that are being priced out of life itself.''</p>
